USD 29.37
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 5 Billion | 2.97 Billion | 3.57 Billion | 3.4 Billion | 3.37 Billion | 2.21 Billion |
Net Income | 1.04 Billion | 1.13 Billion | 1.3 Billion | 770 Million | 1.32 Billion | 1.45 Billion |
Depreciation & Amortization | 2.9 Billion | 2.68 Billion | 2.33 Billion | 2.31 Billion | 2.09 Billion | 1.76 Billion |
Deferred income taxes | 51 Million | -89 Million | 40 Million | -54 Million | 33 Million | -12 Million |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 1.14 Billion | -606 Million | 204 Million | 477 Million | -223 Million | -395 Million |
Other non-cash items | 5.7 Billion | -232 Million | -266 Million | -157 Million | 181 Million | -604 Million |
Investing Cash Flow | -2.32 Billion | -8.63 Billion | -1.24 Billion | -1.6 Billion | -602 Million | -3.08 Billion |
Investments in PPE | -2.66 Billion | -2.73 Billion | -2.53 Billion | -2.64 Billion | -1.87 Billion | -2.34 Billion |
Acquisitions | 652 Million | -6.34 Billion | 757 Million | -291 Million | 955 Million | -1.4 Billion |
Investment purchases | -97 Million | -20 Million | -12 Million | -11 Million | -16 Million | -31 Million |
Sales/Maturities of investments | 91 Million | 16 Million | 8 Million | 4 Million | 13 Million | 80 Million |
Other Investing Activities | -309 Million | 444 Million | 540 Million | 1.34 Billion | 325 Million | 665 Million |
Financing Cash Flow | -3.02 Billion | 4.85 Billion | -284 Million | -1.02 Billion | -1.93 Billion | -1.1 Billion |
Debt repayment | -1.68 Billion | -5.74 Billion | -696 Million | -234 Million | -1.04 Billion | -161 Million |
Dividends payments | -671 Million | -680 Million | -647 Million | -646 Million | -631 Million | -620 Million |
Common Stock Repurchased | -183 Million | -283 Million | -34 Million | -296 Million | - | -22 Million |
Common Stock Issuance | -559 Million | -5.46 Billion | - | 62 Million | 170 Million | - |
Other Financing Activities | 64 Million | 17.02 Billion | -299 Million | 93 Million | -78 Million | -488 Million |
Accounts receivables | -179 Million | -1.02 Billion | -284 Million | 286 Million | -228 Million | -361 Million |
Accounts payables | -35 Million | 746 Million | 243 Million | -130 Million | -52 Million | -161 Million |
Inventory | 179 Million | -235 Million | 70 Million | 356 Million | 182 Million | -290 Million |
Other working capital | 1.18 Billion | -93 Million | 175 Million | -35 Million | -125 Million | 413 Million |
Cash at beginning of period | 5.73 Billion | 6.15 Billion | 4.03 Billion | 3.35 Billion | 2.69 Billion | 4.61 Billion |
Cash at end of period | 5.54 Billion | 5.31 Billion | 6.15 Billion | 4.03 Billion | 3.35 Billion | 2.69 Billion |
Capital Expenditure | -2.66 Billion | -2.73 Billion | -2.53 Billion | -2.64 Billion | -1.87 Billion | -2.34 Billion |
Effect of forex changes on cash | -58 Million | -32 Million | 64 Million | -98 Million | 88 Million | 54 Million |
Net cash flow / Change in cash | -188 Million | -832 Million | 2.11 Billion | 683 Million | 664 Million | -1.92 Billion |
Free Cash Flow | 2.33 Billion | 248 Million | 1.04 Billion | 758 Million | 1.49 Billion | -127 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 332 Million | -146 Million | 1.04 Billion | 375 Million | 480 Million | 415 Million |
Depreciation & Amortization | 705 Million | 670 Million | 2.9 Billion | 808 Million | 760 Million | 635 Million |
Deferred income taxes | - | - | 51 Million | 51 Million | 8 Million | -8 Million |
Stock-based compensation | - | - | - | - | - | 8 Million |
Change in working capital | -628 Million | -966 Million | 1.14 Billion | 3.04 Billion | 61 Million | -1.14 Billion |
Other non-cash items | 1.53 Billion | 1.29 Billion | 5.7 Billion | 1.54 Billion | 146 Million | 34 Million |
Investing Cash Flow | -606 Million | -772 Million | -2.32 Billion | -71 Million | -597 Million | -952 Million |
Investments in PPE | -531 Million | -759 Million | -2.66 Billion | -591 Million | -670 Million | -597 Million |
Acquisitions | -88 Million | 23 Million | 652 Million | 518 Million | 110 Million | -152 Million |
Investment purchases | - | -20 Million | -97 Million | 10 Million | -24 Million | -74 Million |
Sales/Maturities of investments | - | 2 Million | 91 Million | 6 Million | 2 Million | 79 Million |
Other Investing Activities | 13 Million | -18 Million | -309 Million | -14 Million | -15 Million | -208 Million |
Financing Cash Flow | -1.02 Billion | -177 Million | -3.02 Billion | -760 Million | -1.07 Billion | -15 Million |
Debt repayment | -22 Million | -23 Million | -1.68 Billion | -435 Million | -749 Million | -675 Million |
Dividends payments | -718 Million | - | -671 Million | - | - | -671 Million |
Common Stock Repurchased | -46 Million | -55 Million | -183 Million | -181 Million | -2 Million | 65 Million |
Common Stock Issuance | - | - | -559 Million | - | -66 Million | 66 Million |
Other Financing Activities | -93 Million | -77 Million | 64 Million | -7 Million | 560 Million | 1.2 Billion |
Accounts receivables | - | - | -179 Million | -179 Million | - | - |
Accounts payables | - | - | -35 Million | 824 Million | - | - |
Inventory | - | - | 179 Million | 164 Million | - | - |
Other working capital | -628 Million | -966 Million | 1.18 Billion | 2.23 Billion | 61 Million | -1.14 Billion |
Cash at beginning of period | 4.07 Billion | 5.54 Billion | 5.73 Billion | 2.12 Billion | 1.82 Billion | 2.83 Billion |
Cash at end of period | 3.24 Billion | 4.07 Billion | 5.54 Billion | 5.54 Billion | 1.57 Billion | 1.82 Billion |
Capital Expenditure | -531 Million | -759 Million | -2.66 Billion | -591 Million | -670 Million | -597 Million |
Effect of forex changes on cash | 32 Million | 19 Million | -58 Million | -42 Million | -27 Million | 9 Million |
Net cash flow / Change in cash | -823 Million | -1.47 Billion | -188 Million | 3.42 Billion | -251 Million | -1.01 Billion |
Free Cash Flow | - | -1.24 Billion | 2.33 Billion | 3.61 Billion | 777 Million | -654 Million |
RBX
3710
FLUOROCHEM
TBIX
METSA
1948